Oxford COVID-19 vaccine follows its p... - Lung Conditions C...

Lung Conditions Community Forum

55,877 members66,527 posts

Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds.

2greys profile image
5 Replies

The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety. Now a team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team. This novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.

The findings, led by scientists at the University of Bristol and published on the pre-print server ResearchSquare, represent the most in-depth analysis of any of the COVID-19 vaccine candidates, going significantly above and beyond any regulatory requirements anywhere in the world.

medsci.ox.ac.uk/news/oxford...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Troilus profile image
Troilus

Excellent news 2greys. Thank you.

Daisy55 profile image
Daisy55

That’s good news , thank you x

Alberta56 profile image
Alberta56

Gosh. That does sound hopeful

That sounds really promising. Thank you

2greys profile image
2greys

Out of choice, I think this would be the one that I would have. It has shown a good T cell response as well as for antibodies. In my opinion, along with a fair few scientists, B &T cells are a lot more important than antibodies alone. T cells do not fade away like antibodies do. The T cells instruct the B cells to make more antibodies. So it it is actually a T cell response that we should be be looking for in a vaccine.

Not what you're looking for?

You may also like...

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) - Oxford /AstraZenaca has now been peer reviewed.

Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against...

Common IBS/IBD treatment blunts COVID-19 vaccine response.

People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume...

Bronchiectasis and COVID-19 Vaccine

Hello, Anyone here with Bronchiectasis who has taken the Astrazenaca COVID-19 vaccine. Any advise...

Current air pollution tied to more severe COVID-19 outcomes, study finds.

Contemporaneous exposure to air pollution may influence the severity of COVID-19 illness and...

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that...